| Literature DB >> 33758338 |
Yunzhi Peter Yang1,2,3, Kevin M Labus4, Benjamin C Gadomski4, Arnaud Bruyas5, Jeremiah Easley6, Brad Nelson6, Ross H Palmer6, Kirk McGilvray4, Daniel Regan7, Christian M Puttlitz4, Alexander Stahl5,8, Elaine Lui5, Jiannan Li5, Seyedsina Moeinzadeh5, Sungwoo Kim5, William Maloney5, Michael J Gardner5.
Abstract
Autologous bone grafts are considered the gold standard grafting material for the treatment of nonunion, but in very large bone defects, traditional autograft alone is insufficient to induce repair. Recombinant human bone morphogenetic protein 2 (rhBMP-2) can stimulate bone regeneration and enhance the healing efficacy of bone grafts. The delivery of rhBMP-2 may even enable engineered synthetic scaffolds to be used in place of autologous bone grafts for the treatment of critical size defects, eliminating risks associated with autologous tissue harvest. We here demonstrate that an osteoinductive scaffold, fabricated by combining a 3D printed rigid polymer/ceramic composite scaffold with an rhBMP-2-eluting collagen sponge can treat extremely large-scale segmental defects in a pilot feasibility study using a new sheep metatarsus fracture model stabilized with an intramedullary nail. Bone regeneration after 24 weeks was evaluated by micro-computed tomography, mechanical testing, and histological characterization. Load-bearing cortical bridging was achieved in all animals, with increased bone volume observed in sheep that received osteoinductive scaffolds compared to sheep that received an rhBMP-2-eluting collagen sponge alone.Entities:
Year: 2021 PMID: 33758338 PMCID: PMC7987996 DOI: 10.1038/s41598-021-86210-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379